EU-IN_VITRO_MEDICAL_DEVICE_REG-ART_5_2_ANX_1

In Vitro Diagnostic Medical Devices Regulation - Hazardous Substances

EU. Hazardous Substances for Purposes of Art. 5(2) and Annex I of Regulation (EU) 2017/746 on In Vitro Diagnostic Medical Devices, 5 May 2017, as corrected 27 December 2019

This list contains a non-exhaustive inventory of hazardous substances for purposes of Regulation (EU) 2017/746, including Chap. 2 (Placing on the market and putting into service) and Annex I (General Safety and Performance Requirements). It is derived from: Table 3 of Annex VI to CLP, REACH Candidate List of SVHCs, and Directive 2000/54/EC's Annex III (Biological Agents list).

Last updated 26 april 2024. Database contains 4917 unique substances/entries.

Filter the list

Viser 1.801 - 1.850 af 4.917 resultater.

Substance Name	EC No.	CAS No.	EU CLP (1272/2008)	EU_BA Directive 2000/54/EC	EU REACH: List of SVHC
coumachlor (ISO); 3-[1-(4-chlorophenyl)-3-oxobutyl]-4-hydroxycoumarin	201-378-1	81-82-3	STOT RE 2			Details
coumafuryl (ISO); fumarin; (RS)-3-(1-(2-furyl)-3-oxobutyl)4-hydroxycoumarin; 4-hydroxy-3-[3-oxo-1-(2-furyl)butyl]coumarin	204-195-5	117-52-2	Acute Tox. 3; STOT RE 1			Details
coumaphos (ISO); O-3-chloro-4-methylcoumarin-7-yl O,O-diethyl phosphorothioate	200-285-3	56-72-4	Acute Tox. 2; Acute Tox. 4			Details
coumatetralyl; 4-hydroxy-3-(1,2,3,4-tetrahydro-1-naphthyl)coumarin	227-424-0	5836-29-3	Repr. 1B; Acute Tox. 2; Acute Tox. 3; STOT RE 1			Details
coumithoate (ISO); O,O-diethyl O-7,8,9,10-tetrahydro-6-oxo-benzo(c)chromen-3-yl phosphorothioate	-	572-48-5	Acute Tox. 3			Details
Cowpox virus	-	-		V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.		Details
Coxiella burnetii	-	-		B Bacteria and similar species		Details
Coxsackie viruses	-	-		V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.		Details
Creosote [The distillate of coal tar produced by the high temperature carbonization of bituminous coal. It consists primarily of aromatic hydrocarbons, tar acids and tar bases.] The distillate of coal tar produced by the high temperature carbonization of bituminous coal. It consists primarily of aromatic hydrocarbons, tar acids and tar bases.	232-287-5	8001-58-9	Carc. 1B			Details
Creosote oil [A complex combination of hydrocarbons obtained by the distillation of coal tar. It consists primarily of aromatic hydrocarbons and may contain appreciable quantities of tar acids and tar bases. It distills at the approximate range of 200 °C to 325 °C (392°F to 617°F).] A complex combination of hydrocarbons obtained by the distillation of coal tar. It consists primarily of aromatic hydrocarbons and may contain appreciable quantities of tar acids and tar bases. It distills at the approximate range of 200°C to 325°C (392°F to 617°F).	263-047-8	61789-28-4	Carc. 1B			Details
Creosote oil, acenaphthene fraction, acenaphthene-free; Wash Oil Redistillate [The oil remaining after removal by a crystallization process of acenaphthene from acenaphthene oil from coal tar. Composed primarily of naphthalene and alkylnaphthalenes.] The oil remaining after removal by a crystallization process of acenaphthene from acenaphthene oil from coal tar. Composed primarily of naphthalene and alkylnaphthalenes.	292-606-9	90640-85-0	Carc. 1B			Details
Creosote oil, acenaphthene fraction; Wash Oil [A complex combination of hydrocarbons produced by the distillation of coal tar and boiling in the range of approximately 240 o C to 280 o C (464°F to 536 °F). Composed primarily of acenaphthene, naphthalene and alkyl naphthalene.] A complex combination of hydrocarbons produced by the distillation of coal tar and boiling in the range of approximately 240°C to 280°C (464°F to 536°F). Composed primarily of acenaphthene, naphthalene and alkyl naphthalene.	292-605-3	90640-84-9	Carc. 1B			Details
Creosote oil, high-boiling distillate; Wash Oil [The high-boiling distillation fraction obtained from the high temperature carbonization of bituminous coal which is further refined to remove excess crystalline salts. It consists primarily of creosote oil with some of the normal polynuclear aromatic salts, which are components of coal tar distillates, removed. It is crystal free at approximately 5 °C (41°F).] The high-boiling distillation fraction obtained from the high temperature carbonization of bituminous coal which is further refined to remove excess crystalline salts. It consists primarily of creosote oil with some of the normal polynuclear aromatic salts, which are components of coal tar distillates, removed. It is crystal free at approximately 5°C (41°F).	274-565-9	70321-79-8	Carc. 1B			Details
Creosote oil, low-boiling distillate; Wash Oil [The low-boiling distillation fraction obtained from the high temperature carbonization of bituminous coal, which is further refined to remove excess crystalline salts. It consists primarily of creosote oil with some of the normal polynuclear aromatic salts, which are components of coal tar distillate, removed. It is crystal free at approximately 38 o C (100 oF).] The low-boiling distillation fraction obtained from the high temperature carbonization of bituminous coal, which is further refined to remove excess crystalline salts. It consists primarily of creosote oil with some of the normal polynuclear aromatic salts, which are components of coal tar distillate, removed. It is crystal free at approximately 38°C (100°F).	274-566-4	70321-80-1	Carc. 1B			Details
Creutzfeldt-Jakob disease	-	-		V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.		Details
Crimean-Congo haemorrhagic fever	-	-		V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.		Details
crimidine (ISO);2-chloro-6-methylpyrimidin-4- yldimethylamine	208-622-6	535-89-7	Acute Tox. 2			Details
crotonaldehyde; 2-butenal	224-030-0	4170-30-3	Flam. Liq. 2; Muta. 2; Acute Tox. 2; Acute Tox. 3; STOT RE 2; STOT SE 3; Skin Irrit. 2; Eye Dam. 1			Details
crotoxyphos (ISO); 1-phenylethyl 3-(dimethoxyphosphinyloxy) isocrotonate	231-720-5	7700-17-6	Acute Tox. 3			Details
crufomate (ISO); 4-tert-butyl-2-chlorophenyl methyl methylphosphoramidate	206-083-1	299-86-5	Acute Tox. 4			Details
Cryptococcus neoformans var. gattii	-	-		F Fungi		Details
Cryptococcus neoformans var. neofonnans	-	-		F Fungi		Details
Cryptosporidium parvum	-	-		P Parasites		Details
Cryptosporidium spp.	-	-		P Parasites		Details
cumene	202-704-5	98-82-8	Flam. Liq. 3; Carc. 1B; Asp. Tox. 1; STOT SE 3			Details
cyanamide; carbanonitril	206-992-3	420-04-2	Carc. 2; Repr. 2; Acute Tox. 3; STOT RE 2; Skin Corr. 1; Skin Sens. 1; Eye Dam. 1			Details
cyanazine (ISO);2-(4-chloro-6-ethylamino-1,3,5- triazine-2-ylamino)-2-methylpropionitrile	244-544-9	21725-46-2	Acute Tox. 4			Details
cyanofenphos (ISO); O-4-cyanophenyl O-ethyl phenylphosphonothioate	620-377-0	13067-93-1	Acute Tox. 3; STOT SE 1; Acute Tox. 4; Eye Irrit. 2			Details
cyanophos (ISO); O-4-cyanophenyl O,O-dimethyl phosphorothioate	220-130-3	2636-26-2	Acute Tox. 4			Details
cyanthoate (ISO); S-(N-(1-cyano-1-methylethyl)carbamoylmethyl) O,O-diethyl phosphorothioate	223-099-4	3734-95-0	Acute Tox. 2; Acute Tox. 3			Details
cyclanilide (ISO); 1-(2,4-dichloroanilinocarbonyl)cyclopropanecarboxylic acid CSDCA	419-150-7	113136-77-9	Acute Tox. 4			Details
cyclic 3-(1,2-ethanediylacetale)-estra-5(10),9(11)-diene-3,17-dione	427-230-8	5571-36-8	Repr. 1B; STOT RE 2			Details
cyclohexadeca-1,9-diene	431-730-1	4277-06-9	Skin Irrit. 2; Skin Sens. 1			Details
cyclohexane	203-806-2	110-82-7	Flam. Liq. 2; Asp. Tox. 1; Skin Irrit. 2; STOT SE 3			Details
cyclohexane-1,2-dicarboxylic anhydride	201-604-9	85-42-7	Eye Dam. 1; Resp. Sens. 1; Skin Sens. 1		RSP Respiratory sensitising properties (Article 57(f)) - human health)	Details
cyclohexanol	203-630-6	108-93-0	Acute Tox. 4; STOT SE 3; Skin Irrit. 2			Details
cyclohexanone	203-631-1	108-94-1	Flam. Liq. 3; Acute Tox. 4			Details
cyclohexanone, peroxide;cyclohexanone, peroxide [≤ 91 % solution]	235-527-7	12262-58-7	Org. Perox. A; Skin Corr. 1B; Acute Tox. 4			Details
cyclohexanone, peroxide;cyclohexanone, peroxide [≤ 91 % solution]	235-527-7	12262-58-7	Org. Perox. C; Acute Tox. 4; Skin Corr. 1B			Details
cycloheximide (ISO);4-{(2R)-2-[(1S,3S,5S)-3,5- dimethyl-2-oxocyclohexyl]-2- hydroxyethyl}piperidine-2,6- dione	200-636-0	66-81-9	Muta. 2; Repr. 1B; Acute Tox. 2			Details
cyclohexyl acrylate	221-319-3	3066-71-5	STOT SE 3; Skin Irrit. 2			Details
cyclohexylamine	203-629-0	108-91-8	Flam. Liq. 3; Repr. 2; Acute Tox. 4; Skin Corr. 1B			Details
cyclohexyldimethoxymethylsilane CHMMS; CHMS; DYNASYLAN 9407; Z-6187	402-140-1	17865-32-6	Skin Irrit. 2			Details
cyclohexylidene hydroperoxide;cyclohexylidene hydroperoxide [≤ 91 % solution]	220-279-4	2699-11-8	Org. Perox. A; Skin Corr. 1B; Acute Tox. 4			Details
cyclohexylidene hydroperoxide;cyclohexylidene hydroperoxide [≤ 91 % solution]	220-279-4	2699-11-8	Org. Perox. C; Acute Tox. 4; Skin Corr. 1B			Details
cyclooct-4-en-1-yl methyl carbonate VIOLIFF	401-620-8	87731-18-8	Skin Sens. 1			Details
cyclopentane	206-016-6	287-92-3	Flam. Liq. 2			Details
cyclopentane-1,2,3,4-tetracarboxylic dianhydride	227-964-7	6053-68-5	Eye Irrit. 2; STOT SE 3			Details
cyclopentanone	204-435-9	120-92-3	Flam. Liq. 3; Eye Irrit. 2; Skin Irrit. 2			Details
cyclopentyl 2-phenylethyl ether	428-340-9	238088-70-5	Skin Irrit. 2			Details

Viser 1.801 - 1.850 af 4.917 resultater.

Export search results to:

EU-IN_VITRO_MEDICAL_DEVICE_REG-ART_5_2_ANX_1

EU-IN_VITRO_MEDICAL_DEVICE_REG-ART_5_2_ANX_1

In Vitro Diagnostic Medical Devices Regulation - Hazardous Substances

EU. Hazardous Substances for Purposes of Art. 5(2) and Annex I of Regulation (EU) 2017/746 on In Vitro Diagnostic Medical Devices, 5 May 2017, as corrected 27 December 2019

RELEVANT LEGISLATION

Contact EUCLEF Helpdesk

Last updated 26 april 2024. Database contains 4917 unique substances/entries.

Footer Nav Items